[The role of PGI2 and TXA2 in the pathogenesis of endotoxin-induced lung injury].
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D004285:Dogs; D004731:Endotoxins / Q000009:adverse effects*; D011464:Epoprostenol / Q000627:therapeutic use*; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects; D008171:Lung Diseases / Q000139:chemically induced* / Q000517:prevention & control; D010477:Perfusion; D013928:Thromboxane A2 / Q000502:physiology*
D004731:Endotoxins; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol